Expanded Indications for Hodgkin and CLL Drugs in Europe ...Middle East

Medscape - News
Expanded Indications for Hodgkin and CLL Drugs in Europe
The EMA has recommended extensions to the marketing authorizations for Adcetris, used to treat Hodgkin lymphoma, and Calquence, indicated for chronic lymphocytic leukemia. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Expanded Indications for Hodgkin and CLL Drugs in Europe )

Also on site :